Hims & Hers Health Inc. ($HIMS) Stock Forecast: Up 9.0% Today

What is Hims & Hers Health Inc.?

Hims & Hers Health, Inc. (HIMS) saw significant bullish movement today.

Why is Hims & Hers Health Inc. going up?

HIMS stock is up 9.0% on Jul 30, 2025 18:40

• Strong product demand and subscriber growth ahead of Q2 earnings are driving HIMS stock higher.
• The bearish trend in Novo Nordisk (NVO) following a warning related to its weight-loss drug Wegovy could be benefiting HIMS as an alternative.
• Despite class action lawsuits and shareholder alerts, HIMS outperformed the broader market, indicating resilience and investor confidence.
• The upcoming deadline for investors to file a Lead Plaintiff Motion with a law firm may have also contributed to the positive momentum in HIMS stock.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?

Hims & Hers benefits from strong product demand and subscriber growth ahead of second-quarter 2025 earnings, fueled by weight loss and specialty care uptake.

https://www.zacks.com/stock/news/2639754/can-sustained-product-demand-drive-hims-stock-before-q2-earnings

Novo Nordisk Charts Signal Weakness Amid Wegovy Warning, Expert Says 'Could've Played Out VERY Differently If They Had Embraced $HIMS' - Hims & Hers Health ( NYSE:HIMS ) , Novo Nordisk ( NYSE:NVO )

Weight-loss drugmaker Novo Nordisk A/S NVO's technical chart is displaying a largely bearish trend amid a profit warning issued by the company tied to its blockbuster obesity drug Wegovy.

https://www.benzinga.com/markets/equities/25/07/46716995/novo-nordisk-charts-signal-weakness-amid-wegovy-warning-expert-says-couldve-played-out-very-diff

HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS - Hims & Hers Health ( NYSE:HIMS )

NEW YORK and NEW ORLEANS, July 29, 2025 ( GLOBE NEWSWIRE ) -- Kahn Swick & Foti, LLC ( "KSF" ) and KSF partner, former Attorney General of Louisiana, Charles C.

https://www.benzinga.com/pressreleases/25/07/g46710937/hims-hers-health-shareholder-alert-by-former-louisiana-attorney-general-kahn-swick-foti-llc-remind

Hims & Hers Health, Inc. ( HIMS ) Outperforms Broader Market: What You Need to Know

In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $58.68, indicating a +1.79% shift from the previous trading day.

https://www.zacks.com/stock/news/2630630/hims-hers-health-inc-hims-outperforms-broader-market-what-you-need-to-know

Hims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion - Hims & Hers Health ( NYSE:HIMS )

Investors can contact the law firm at no cost to learn more about recovering their losses

https://www.benzinga.com/pressreleases/25/07/g46674858/hims-hers-health-inc-please-contact-the-portnoy-law-firm-to-recover-your-losses-august-25-2025-dea

Trending Today

Gasoline ($GASOLINE) Commodity Forecast: Down 0.7% Today

Bitcoin Cash ($BCH) Crypto Forecast: Up 5.3% Today

Copper ($COPPER) Commodity Forecast: Down 18.5% Today

FedEx Corporation ($FDX) Stock Forecast: Down 5.0% Today

IDEX Corporation ($IEX) Stock Forecast: Down 11.4% Today

DTE Energy Company ($DTE) Stock Forecast: Down 1.3% Today

Teradyne, Inc. ($TER) Stock Forecast: Up 19.1% Today

Automatic Data Processing Inc. ($ADP) Stock Forecast: Up 1.1% Today

Credo Technology Group ($CRDO) Stock Forecast: Up 5.1% Today

Adobe Inc. ($ADBE) Stock Forecast: Down 2.0% Today

Hims & Hers Health Inc. Price History

24.06.2025 - HIMS Stock was up 9.4%

• HIMS stock rose by 16% recently, amid an ongoing uptrend despite legal issues, including securities fraud allegations and lawsuits.
• Investor sentiment has been buoyed by analysts' optimism and raised price targets, with Truist Securities lifting its target to $48.
• Strong performance is attributed to strategic decisions like the ZAVA acquisition, expansion into the Canadian market, and optimistic earnings per share (EPS) estimates.
• The market appears more focused on the company's growth strategies and potential, overshadowing current legal hurdles and propelling the bullish trend in HIMS stock.

09.06.2025 - HIMS Stock was up 5.2%

• Plans have been announced by Hims & Hers Health to extend its weight loss program into Canada by 2026, showcasing the potential for growth in a new market.
• Investor optimism in the options market reflects confidence in the company's future and its ability to deliver positive financial results.
• Despite a class action securities lawsuit, the stock demonstrated resilience and positive momentum, potentially fueled by the positive outlook for expansion and digital health initiatives.
• The company's expanding services, strong investor confidence, and innovative healthcare approach may have all contributed to the stock's bullish performance today.

09.06.2025 - HIMS Stock was up 5.8%

• The recent class action securities lawsuit does not appear to have significantly affected the stock price, with investors focusing more on the company's positive digital wellness initiatives.
• The bullish activity observed in the options market suggests a high level of investor confidence in HIMS' future performance.
• Despite ongoing legal challenges, market interest seems to be more aligned with the company's innovative approach to wellness, as evidenced by the stock's upward movement.
• Overall, market sentiment towards HIMS seems driven by optimism regarding its digital healthcare offerings rather than legal concerns.

29.06.2025 - HIMS Stock was up 5.1%

• The bullish movement in HIMS stock could be attributed to positive market sentiment driven by expectations of earnings growth, as Wall Street anticipates a strong performance in the upcoming report.
• Despite facing a lawsuit for securities fraud, investors seem optimistic about the company's future prospects, possibly due to the potential for strategic expansion and earnings growth.
• The announcement of a lawsuit by BFA Law may have initially caused some uncertainty in the market, but the resilience shown by Hims & Hers Health, Inc. in outperforming the broader market indicates that investors are focusing more on the company's long-term potential rather than short-term legal challenges.

30.06.2025 - HIMS Stock was up 10.0%

• HIMS stock experienced a strong bullish movement today, outperforming the broader market with a +1.79% shift.
• The positive market movement could be attributed to the company's resilience and growth potential in the direct-to-consumer health sector.
• The bearish trend in Novo Nordisk (NVO) might have indirectly benefited HIMS, as investors could have shifted focus towards HIMS due to concerns surrounding NVO's obesity drug.
• The ongoing comparison between HIMS and Teladoc Health in terms of earnings growth and strategic expansion could have also contributed to increased investor interest in HIMS, driving the bullish movement.

15.06.2025 - HIMS Stock was up 5.8%

• Despite dealing with a class action securities lawsuit and allegations of fraud, HIMS stock demonstrated resilience and bullish momentum.
• Investors appear to be concentrating on the company's market leadership and growth potential, rather than its current legal hurdles.
• The upward trend in the stock price may be linked to favorable market sentiment towards the company's innovative offerings, overshadowing the legal uncertainties.
• Despite ongoing legal challenges and investor alerts, investor confidence in Hims & Hers Health, Inc. does not appear to have been significantly affected, as evidenced by the stock's bullish performance.

14.06.2025 - HIMS Stock was up 5.4%

• Despite a class action lawsuit and allegations of fraud in its past, HIMS stock showed strong bullish movement.
• Investor sentiment remains positive towards the company's future outlook, overlooking current legal challenges.
• The market appears to be factoring in growth potential and positive internal developments that overshadow legal uncertainties.
• Investors may be emphasizing the company's market dominance and service demand over short-term legal hurdles.

08.06.2025 - HIMS Stock was up 6.1%

• The bullish movement in HIMS stock today can be attributed to several factors:
• The positive sentiment from investors taking a bullish stance on the company in the options market indicates confidence in its future prospects.
• Despite facing class action lawsuits and investor alerts, the company's innovative approach to reshaping everyday wellness seems to have resonated well with shareholders and potential investors.
• The transformation of digital wellness and the alignment with Gen Z preferences could be driving increased interest and investment in Hims & Hers Health.
• The ongoing investigations and lawsuits might have created some volatility, but the overall market sentiment appears to be optimistic about the company's growth potential in the digital health sector.

22.06.2025 - HIMS Stock was up 5.9%

• The acquisition of ZAVA and the planned launch in Canada for affordable obesity care have fueled investor optimism and contributed to the bullish movement.
• Despite the market gains, the stock experienced a temporary drop, possibly due to profit-taking or short-term market fluctuations.
• The securities fraud class action lawsuit against HIMS may have initially caused some uncertainty among investors, but the positive news overshadowed this, leading to the bullish trend.
• The interest of smart money in bearish options on HIMS might have created some volatility, but overall, the company's strategic moves seem to have driven the stock's upward trajectory.

23.06.2025 - HIMS Stock was up 9.5%

• HIMS stock demonstrated a strong bullish movement recently, possibly influenced by favorable developments related to its expansion and acquisition plans.
• The acquisition of ZAVA and the forthcoming launch of affordable obesity care services in Canada are believed to have increased investor confidence in the company's future growth.
• Despite some legal troubles including class action lawsuits, overall market sentiment appears upbeat regarding HIMS' growth prospects, resulting in the positive performance of its stock.
• Investors seem to be placing more emphasis on HIMS' strategic initiatives and growth opportunities over near-term legal challenges, contributing to the upward momentum in the company's stock price.

18.06.2025 - HIMS Stock was down 5.0%

• Smart money investors have taken a bearish stance on HIMS options, reflecting limited confidence in the stock's short-term performance.
• The pending class action lawsuit against Hims & Hers Health may have contributed to investor uncertainty and selling pressure on the stock.
• Despite recent surges in stock price driven by robust online revenue and subscriber growth, potential challenges ahead might be influencing investor sentiment and leading to the bearish movement.
• The prevailing negative market sentiment towards HIMS, as observed in the decrease in stock price relative to the broader market, indicates investor caution regarding the company's future prospects.

30.06.2025 - HIMS Stock was up 9.0%

• Strong product demand and subscriber growth ahead of Q2 earnings are driving HIMS stock higher.
• The bearish trend in Novo Nordisk (NVO) following a warning related to its weight-loss drug Wegovy could be benefiting HIMS as an alternative.
• Despite class action lawsuits and shareholder alerts, HIMS outperformed the broader market, indicating resilience and investor confidence.
• The upcoming deadline for investors to file a Lead Plaintiff Motion with a law firm may have also contributed to the positive momentum in HIMS stock.